SG144065A1 - Oral contraceptive spray - Google Patents
Oral contraceptive sprayInfo
- Publication number
- SG144065A1 SG144065A1 SG200718578-8A SG2007185788A SG144065A1 SG 144065 A1 SG144065 A1 SG 144065A1 SG 2007185788 A SG2007185788 A SG 2007185788A SG 144065 A1 SG144065 A1 SG 144065A1
- Authority
- SG
- Singapore
- Prior art keywords
- spray
- oral contraceptive
- contraceptive
- oral
- formulation
- Prior art date
Links
- 229940127234 oral contraceptive Drugs 0.000 title abstract 2
- 239000003539 oral contraceptive agent Substances 0.000 title abstract 2
- 239000007921 spray Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 229940124532 absorption promoter Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 abstract 1
- 229960002941 etonogestrel Drugs 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06125961 | 2006-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG144065A1 true SG144065A1 (en) | 2008-07-29 |
Family
ID=38521609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200718578-8A SG144065A1 (en) | 2006-12-12 | 2007-12-12 | Oral contraceptive spray |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100105641A1 (es) |
| EP (1) | EP2120874A2 (es) |
| AR (1) | AR064602A1 (es) |
| CA (1) | CA2671469A1 (es) |
| CL (1) | CL2007003592A1 (es) |
| MX (1) | MX2009006316A (es) |
| PE (1) | PE20081403A1 (es) |
| SG (1) | SG144065A1 (es) |
| TW (1) | TW200840595A (es) |
| WO (1) | WO2008071429A2 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009101182A1 (en) * | 2008-02-15 | 2009-08-20 | N.V. Organon | Use of etonogestrel for benign prostate hyperplasia (bph). |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK174724B1 (da) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet |
| DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
| AU2190697A (en) * | 1996-04-12 | 1997-11-07 | Flemington Pharmaceutical Corporation | Buccal polar spray or capsule |
| IL123813A0 (en) * | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
| US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
| US6506742B2 (en) * | 1999-12-13 | 2003-01-14 | Ortho-Mcneil Pharmaceutical, Inc. | Soluble contraceptive liquid formulation |
| WO2003068315A1 (en) * | 2002-02-15 | 2003-08-21 | Pantarhei Bioscience B.V. | A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males |
| AU2003296810A1 (en) * | 2002-12-10 | 2004-07-09 | Besins International Belgique | Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof |
-
2007
- 2007-12-07 TW TW096146841A patent/TW200840595A/zh unknown
- 2007-12-11 CA CA002671469A patent/CA2671469A1/en not_active Abandoned
- 2007-12-11 WO PCT/EP2007/010954 patent/WO2008071429A2/en not_active Ceased
- 2007-12-11 CL CL200703592A patent/CL2007003592A1/es unknown
- 2007-12-11 US US12/518,732 patent/US20100105641A1/en not_active Abandoned
- 2007-12-11 PE PE2007001765A patent/PE20081403A1/es not_active Application Discontinuation
- 2007-12-11 EP EP07856699A patent/EP2120874A2/en not_active Withdrawn
- 2007-12-11 MX MX2009006316A patent/MX2009006316A/es active IP Right Grant
- 2007-12-12 AR ARP070105558A patent/AR064602A1/es unknown
- 2007-12-12 SG SG200718578-8A patent/SG144065A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20081403A1 (es) | 2008-10-04 |
| WO2008071429A3 (en) | 2008-10-09 |
| MX2009006316A (es) | 2009-06-23 |
| CA2671469A1 (en) | 2008-06-19 |
| TW200840595A (en) | 2008-10-16 |
| WO2008071429A2 (en) | 2008-06-19 |
| AR064602A1 (es) | 2009-04-15 |
| CL2007003592A1 (es) | 2008-06-20 |
| US20100105641A1 (en) | 2010-04-29 |
| EP2120874A2 (en) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA96124C2 (ru) | Фармацевтический пенный состав, который включает имиквимод | |
| MX2010005385A (es) | Medicamentos topicos para la terapia antimicotica. | |
| IL178302A (en) | Use of Natalizumab in the preparation of a drug to reduce the need for steroid therapy | |
| WO2006015259A3 (en) | Compounds and compositions as modulators of steroid hormone nuclear receptors | |
| WO2007001888A3 (en) | New regimens for controlled drug delivery devices for contraception | |
| CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
| BRPI1009823A2 (pt) | "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." | |
| WO2008003050A3 (en) | Gallium nitrate formulations | |
| UY30461A1 (es) | Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas. | |
| CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. | |
| MA31201B1 (fr) | Compositions pharmaceutiques comprenant un agent calcilytique | |
| TW200630352A (en) | Chemical compounds | |
| IL187632A (en) | 17 – Ethinyl – 17 – Hydroxy – 13 – Methyl – 17,16,15,14,13,12,11,9,8,7 – Dachahydro – 6 h– Cyclopentane [a] Penanthran – 3 – Ilmethyl ester of acetoxy acid Acetic, a pharmaceutical dosage unit containing it and its use in the preparation of a contraceptive | |
| EP1584335A3 (en) | Active substance combination comprising a carbinol composition and an opioid | |
| MX2009003660A (es) | Farmaco combinado. | |
| WO2009125944A3 (ko) | 비디히드로피리딘계 칼슘 채널 차단제 및 안지오텐신-2 수용체 차단제를 포함하는 약제학적 제제 | |
| SG144065A1 (en) | Oral contraceptive spray | |
| WO2010029093A3 (en) | Compositions for percutaneous administration | |
| NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
| WO2007121471A3 (en) | Dialkyl ether delivery agents | |
| PT1742927E (pt) | Derivados do ácido butanóico, processos para a sua preparação, composições farmacêuticas que os contêm, e suas aplicações terapêuticas | |
| WO2007011958A3 (en) | Intraoral dosage forms of glucagon | |
| WO2007009691A3 (en) | Combination of substituted pyrazolines and anti -addictive agent | |
| NO20064783L (no) | Opplosningstabeletter med licarbazepin | |
| TW200744610A (en) | New regimens for controlled drug delivery devices for contraception |